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Introduction
The spindle assembly checkpoint (SAC) ensures correct chro-
mosome segregation by providing time for proper kinetochore 
(KT) attachment to spindle microtubules (MTs) through inhi-
bition of the anaphase-promoting complex (APC; Musacchio 
and Salmon, 2007). Critical to this inhibition is the repression 
of the APC activator Cdc20 by Mad2, thereby preventing pre-
mature degradation of cyclin B and securin. Mad2 exists in 
two distinct pools at KTs: one that is stable and another with 
high turnover (Shah et al., 2004; Vink et al., 2006). The stable 
pool of Mad2 is bound to Mad1, adopting a structural confor-
mation known as closed-Mad2 (c-Mad2; Sironi et al., 2002; 
Luo et al., 2004; De Antoni et al., 2005; Mapelli et al., 2007). 
The Mad1–c-Mad2 complex at unattached KTs acts as a re-
ceptor for an inactive cytosolic open-Mad2 (o-Mad2) con-
former that is converted into active c-Mad2 by binding to this 
template. c-Mad2 is selectively incorporated into the mitotic 
checkpoint complex (MCC), which is composed of Cdc20, 
BubR1, and Bub3 and inhibits the APC (Sudakin et al., 2001; 
Sironi et al., 2002; Luo et al., 2004; Mapelli et al., 2007; 
Tipton et al., 2011; Chao et al., 2012).
In addition to their localization to KTs, Mad1 and Mad2 
are also recruited to the nuclear pore complex (NPC) by the inner 
nuclear pore protein Tpr, which has been shown to be required 
for normal SAC response from yeast to humans (Campbell et al., 
2001; Ikui et al., 2002; Iouk et al., 2002; Scott et al., 2005; 
Lee et al., 2008; De Souza et al., 2009; Lince-Faria et al., 
2009; Ding et al., 2012). However, the underlying molecular 
mechanism remains unclear. Here, we dissect how human Tpr 
regulates the SAC response and propose a mechanism by which 
Tpr association with Mad1 and Mad2 ensures proper SAC 
proteostasis throughout the cell cycle that is required to mount 
and sustain a robust SAC response.
Tpr is a conserved nuclear pore complex (NPC) pro-tein implicated in the spindle assembly checkpoint (SAC) by an unknown mechanism. Here, we show 
that Tpr is required for normal SAC response by stabi-
lizing Mad1 and Mad2 before mitosis. Tpr coimmuno-
precipitated with Mad1 and Mad2 (hereafter designated 
as Tpr/Mad1/Mad2 or TM2 complex) during interphase 
and mitosis, and is required for Mad1–c-Mad2 recruit-
ment to NPCs. Interestingly, Tpr was normally undetect-
able at kinetochores and dispensable for Mad1, but not 
for Mad2, kinetochore localization, which suggests that 
SAC robustness depends on Mad2 levels at kinetochores. 
Protein half-life measurements demonstrate that Tpr stabi-
lizes Mad1 and Mad2, ensuring normal Mad1–c-Mad2 
production in an mRNA- and kinetochore-independent 
manner. Overexpression of GFP-Mad2 restored normal 
SAC response and Mad2 kinetochore levels in Tpr- 
depleted cells. Mechanistically, we provide evidence that 
Tpr might spatially regulate SAC proteostasis through the 
SUMO-isopeptidases SENP1 and SENP2 at NPCs. Thus, 
Tpr is a kinetochore-independent, rate-limiting factor re-
quired to mount and sustain a robust SAC response.
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This would be consistent with previous work in yeast that 
showed that alteration of the normal Mad1/Mad2 ratio com-
promises SAC response (Barnhart et al., 2011). Importantly, 
c-Mad2 levels at unattached KTs are also reduced after Tpr 
depletion using a distinct siRNA target sequence (Rajanala and 
Nandicoori, 2012) and are restored by expression of RNAi-
resistant mouse Tpr-GFP (Figs. 2 B and S1, A–D), ruling out 
possible Mad2 off-targeting effects. Altogether, these results 
indicate that normal localization of c-Mad2 and o-Mad2 to un-
attached KTs is compromised after Tpr depletion.
The reduction of o-Mad2 at KTs in Tpr-depleted cells 
might reflect a proportional reduction of its KT receptor, c-Mad2, 
or altered turnover at KTs. To distinguish between these pos-
sibilities, we performed FRAP analysis of GFP-Mad2 at KTs 
in control and Tpr-depleted cells treated with nocodazole. In 
both conditions, GFP-Mad2 displays indistinguishable, rapid 
recovery with single exponential kinetics (control, t1/2 = 6 ± 
8 s, n = 10 KTs; Tpr RNAi, t1/2 = 4 ± 3 s, n = 8 KTs; me-
dian ± SD, P = 0.22) with a similar extent of recovery (control, 
58 ± 18%, n = 10 KTs; Tpr RNAi, 57 ± 14%, n = 8 KTs; 
median ± SD, P = 0.22; Fig. 2 C). These findings demonstrate 
that Tpr does not impact Mad2 dynamics at unattached KTs, 
which suggests that Tpr promotes the localization of c-Mad2 
to unattached KTs and is rate-limiting for the conversion of 
o-Mad2 into cytoplasmic c-Mad2.
Tpr interacts with Mad1 and Mad2 
throughout the cell cycle
Tpr interacts with Mad1 and Mad2 (Lee et al., 2008; Lince-Faria 
et al., 2009). To investigate the nature of these interactions, 
we isolated GFP-Mad1 from nocodazole-arrested mitotic 
cells using a cross-linking strategy and mass spectrometry. 
In parallel, we performed coimmunoprecipitation (co-IP) ex-
periments with endogenous Mad1 in asynchronous or mi-
totic enriched populations (Fig. 3 B). We found that Mad1 
associates with Tpr, cyclin B/Cdk1, and Mad2, but failed to 
detect Cdc20, BubR1, or Bub3 (Fig. 3, A and B), which sug-
gests that the TM2 complex exists independently of the MCC 
throughout the cell cycle. Importantly, IP of a GFP-Mad1 mu-
tant (KVLHM-5A) that is unable to interact with Mad2 (Kim 
et al., 2012) also isolated Tpr, which suggests that Tpr inter-
action with Mad1 is independent of Mad2 (Fig. 3 A). To test 
where these proteins interact, we performed an in situ proxim-
ity ligation assay (PLA; Söderberg et al., 2006). This revealed 
abundant fluorescent PLA foci between Tpr and Mad1 at the 
nuclear periphery, likely corresponding to NPCs (Fig. 3, C and D). 
Tpr depletion by RNAi or a PLA reaction between the core 
nuclear pore protein Nup107 and Mad1 abolished the forma-
tion of fluorescent foci (Fig. 3, C and D). No Tpr/Mad1 PLA 
foci were ever detected at unattached KTs in cells treated with 
nocodazole (Fig. 3 C). These findings, together with our IP 
experiments, strongly suggest that Tpr interacts with Mad1 at 
the nuclear envelope during interphase, but not at KTs during 
mitosis. Consistent with this conclusion, Tpr depletion disrupted 
the localization of both Mad1 and c-Mad2 at NPCs during 
interphase (Fig. 3 E).
Results and discussion
Tpr is required to sustain a  
robust SAC response
To determine whether Tpr contributes to SAC robustness, we 
analyzed mitotic duration using live-cell imaging in control 
and Tpr-depleted HeLa cells after RNAi, with and without no-
codazole (Fig. 1, A–C). Control cells progressed from nuclear 
envelope breakdown (NEB) to anaphase in 24 ± 5 min, whereas 
Tpr-depleted cells took 22 ± 5 min (median ± SD, n = 100 cells/
condition; Fig. 1 B). This difference is statistically significant 
(P < 0.01), especially in the presence of nocodazole (control = 16.5 ± 
7.6 h, Tpr RNAi 11.7 ± 7.1 h; median ± SD, n = 350 cells/condi-
tion, P < 0.001; Fig. 1, A and C). Most cells in either experimental 
condition died after this prolonged mitotic arrest, but cell death 
occurs significantly earlier in Tpr-depleted cells (control, 15.0 ± 
7.0 h; Tpr RNAi, 11.4 ± 6.9 h; median ± SD, n = 320 cells/con-
dition, P < 0.001; Fig. 1, D and F). A minor fraction of cells un-
dergo mitotic slippage, which also occurs significantly earlier in 
Tpr-depleted cells (control, 29.2 ± 6.2 h; Tpr RNAi, 13.3 ± 8.8 h; 
median ± SD, n = 30 cells/condition, P < 0.001; Fig. 1, E and F). 
Together, 40% of Tpr-depleted cells exit mitosis during the 
first 10 h of nocodazole treatment, a twofold increase relative to 
controls (Fig. 1 G).
To confirm the specificity of the phenotype, we performed 
a rescue experiment using HeLa cells stably expressing an 
RNAi-resistant mouse Tpr fused to GFP (Fig. 1 H), which inter-
acts with human Mad1 and Mad2 (Hutchins et al., 2010). Tpr-
GFP–expressing cells depleted of endogenous Tpr spent equivalent 
times in mitosis after nocodazole treatment when compared 
with control HeLa cells (19 ± 5.7 h vs. 16.5 ± 7.6 h; median ± SD, 
n = 103 cells, P = 0.07; Fig. 1 I), demonstrating the specificity 
of the Tpr depletion phenotypes. Thus, Tpr is required for a ro-
bust SAC response, supporting previous claims for the existence 
of intermediate response regimens (Lince-Faria et al., 2009) 
that cannot be explained by “all-or-nothing” SAC models.
Tpr is required for the localization of  
a fraction of c-Mad2, but not Mad1,  
to unattached KTs
We have been unable to detect endogenous or GFP-tagged Tpr 
at KTs by fluorescence microscopy (Lince-Faria et al., 2009; 
and unpublished data). Previous studies also reported conflict-
ing findings regarding the effect of Tpr depletion on the KT 
localization of the SAC proteins Mad1 and Mad2 (Lee et al., 
2008; Lince-Faria et al., 2009). To clarify this, we performed 
quantitative immunofluorescence microscopy with specific anti-
bodies against Cdc20, BubR1, Mad1, and total Mad2 (t-Mad2), 
as well as the c-Mad2 (Fava et al., 2011) and o-Mad2 (Hewitt 
et al., 2010) conformers, in nocodazole-treated control and 
Tpr-depleted cells (Fig. 2 A). After Tpr RNAi, t-Mad2 levels 
at KTs decrease by 50%, with equivalent reductions in the 
levels of c-Mad2 and o-Mad2 (Fig. 2 B). In contrast, Mad1 
levels at KTs increase by 40%, whereas Cdc20 and BubR1 
increase by 80% (Fig. 2 B), which might reflect a feedback 
response caused by an effective reduction of cytosolic MCC. 
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Mad1–c-Mad2 before their targeting to KTs. To test this 
hypothesis, we performed IP experiments to investigate the 
amount of Mad1–c-Mad2 produced in asynchronous and mi-
totic extracts. We found that Tpr depletion results in 50% 
Tpr is rate-limiting for the amount of 
Mad1–c-Mad2 produced before mitosis
The previous data raised the possibility that Tpr may func-
tion as a scaffold for regulating the assembly or stability of 
Figure 1. Tpr is required for a robust SAC response. (A) Live cell analysis of control and Tpr-depleted HeLa cells after nocodazole treatment. Bar, 10 µm. 
(B) Tpr depletion reduces the time from NEB to anaphase (ANA) onset. The data shown are from a single representative experiment (control, 24 ± 5 min, 
n = 100 cells; Tpr RNAi, 22 ± 5 min, n = 100 cells; median ± SD, P < 0.05) out of two independent experiments. (C) Tpr-depleted cells spend less time in 
mitosis when challenged with nocodazole. The data shown are from a single representative experiment (control, 16.5 ± 7.6 h, n = 350 cells; Tpr RNAi, 
11.7 ± 7.1 h, n = 360 cells; median ± SD, P < 0.001) out of two independent experiments. (D and F) Most control and Tpr-depleted cells die after a 
prolonged mitotic arrest, but death occurs earlier after Tpr RNAi. The data shown are from a single representative experiment (control, 15 ± 7 h, n = 315 
cells; Tpr RNAi, 11 ± 6.9 h, n = 336 cells; median ± SD, P < 0.001) out of two independent experiments. (E) Tpr RNAi cells slip out of mitosis earlier than 
controls. The data shown are from a single representative experiment (control, 29.2 ± 6.2 h, n = 35 cells; Tpr RNAi, 13.3 ± 8.8 h, n = 24 cells; median ± 
SD, P < 0.001) out of two independent experiments. (G) Twice as many Tpr-depleted cells exit mitosis during the first 10 h in nocodazole relative to controls 
(n = 710 cells from a single representative experiment out of two independent experiments). (H) WB analysis of Tpr from asynchronous control (+) and 
Tpr-depleted () HeLa cells stably expressing RNAi-resistant Tpr-GFP. -Tubulin was used as loading control. (I) Time spent in mitosis after nocodazole in 
control and Tpr-depleted HeLa cells with and without expression of RNAi-resistant Tpr-GFP or GFP-Mad2. Expression of Tpr-GFP rescues mitotic timing. The 
data shown are from a single representative experiment (19 ± 5.7 h, n = 103 cells; median ± SD, P > 0.05). Cells overexpressing Mad2 spent slightly 
less time in mitosis. The data shown are from a single representative experiment (15.8 ± 7.6 h, n = 115 cells; median ± SD, P < 0.05). Boxes represent 
interquartile distributions and whiskers represent 5th and 95th percentiles. n.s., not significant. **, P < 0.01; ***, P < 0.001.
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Figure 2. Tpr is required for c-Mad2, but not Mad1, localization at unattached KTs. (A) Immunofluorescence of nocodazole-treated control and Tpr-depleted 
HeLa cells with the indicated antibodies. Bar, 5 µm. (B) Normalized fluorescence signals at KTs from Tpr-depleted cells relative to controls (set to 1). Error bars 
represent standard deviations from the mean obtained from two or three independent experiments. Green and red boxes correspond to parental HeLa cells. 
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Gray boxes correspond to HeLa cells stably expressing Tpr-GFP or GFP-Mad2. (C) FRAP of GFP-Mad2 in control and Tpr-depleted HeLa cells. Data points 
represent means obtained from 10 (control) or 8 (Tpr RNAi) KTs, to which a single exponential curve was fit. Error bars represent standard deviation.
 
Figure 3. Tpr interacts with Mad1 and Mad2 throughout the cell cycle. (A) LAP-Mad1 purification followed by mass spectrometry analysis reveals interac-
tions with Mad2, Cyclin B, Cdk1, and Tpr during mitosis. A Mad1 mutant (KVLHM-5A) that does not bind Mad2 is still able to interact with Tpr. (B) IP from 
asynchronous (Async) and mitotic HeLa cells (Mitosis) using a Mad1 antibody. I, input; PC, pre clear; IP, immunoprecipitated; NB, nonbinding fraction. All 
fractions were analyzed by WB for detection of Tpr, Mad1, and t-Mad2. (C) 3D image projections from PLA experiments between Tpr and Mad1 at NPCs 
in interphase and unattached KTs in mitotic HeLa cells treated with nocodazole. Green foci indicate a positive reaction, and nuclei/chromosomes were 
counterstained with DAPI. PLA between Nup107 and Mad1, as well as between Tpr and Mad1 upon Tpr RNAi were used as negative controls. Bars, 5 µm. 
(D) Quantification of the PLA foci at the nuclear envelope (NE) for Tpr/Mad1, Nup107/Mad1, and Tpr/Mad1 upon Tpr RNAi in interphase. Error bars rep-
resent standard deviations from three independent experiments. (E) Immunofluorescence with Tpr, Mad1, and c-Mad2 antibodies. Tpr depletion prevented 
Mad1 and c-Mad2 localization at the nuclear envelope. + and  signs indicate nondepleted and depleted cells, respectively. Bar, 10 µm.
reduction of Mad1 and Mad2 that co-IP in both asynchronous 
and mitotic populations (Fig. 4, A and B). Importantly, we 
found that the starting amount of Mad1 and Mad2 present in 
the extracts (input) proportionally decreases after Tpr deple-
tion (Fig. 4, A and B), which suggests that Tpr affects the cellular 
pool of Mad1 and Mad2.
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the available pool of all the other SAC proteins interacting with 
Tpr, including Tpr itself (Fig. 4 E).
Tpr associates with Mad1–c-Mad2 
independently of KTs and Mps1  
kinase activity
Mps1 kinase activity is essential to recruit Mad1–c-Mad2 to 
unattached KTs (Maciejowski et al., 2010; Santaguida et al., 
2010; Sliedrecht et al., 2010; Fig. S2, A–C). Thus, the decrease 
in Mad2 levels at unattached KTs observed after Tpr RNAi 
may be a consequence of reduced Mps1 levels or activity. To 
test these possibilities, we started by partially depleting Mps1 
To test whether Tpr is required for the expression or 
stability of SAC-related proteins, we performed a semiquan-
titative Western blot (WB) analysis using asynchronous and 
mitotic extracts derived from control and Tpr-depleted cells. 
We found that the protein levels of Mad1, Mad2, and Mps1, 
but not Cdc20, decrease after Tpr depletion (Fig. 4 C). More-
over, the observed decrease was proportional to the extent of 
Tpr depletion (Fig. 4 D). Overall, these data suggest that the 
interaction between Tpr, Mad1, Mad2, and Mps1 is rate-limiting 
for the amount of Mad1–c-Mad2 produced before mitosis. In 
support of this hypothesis, we found that even partial knock-
down of Mad1, Mad2, or Mps1 in asynchronous cells decreases 
Figure 4. Tpr regulates the available amount of Mad1–c-Mad2. (A) IP of Mad1 from asynchronous (Async) and mitotic (Mitosis) HeLa cells with or without 
Tpr. (B) IP of c-Mad2 from asynchronous and mitotic HeLa cells with or without Tpr. Note the decrease of coimmunoprecipitated Mad1–c-Mad2 after Tpr 
RNAi. (C) WB analysis of asynchronous and mitotic HeLa cell extracts from control and Tpr-depleted cells to detect the indicated proteins. Note the reduc-
tion of Mps1, Mad1, and Mad2 after Tpr RNAi indicated by the respective percentage relative to controls. (D) WB analysis of mitotic HeLa cells to detect 
the indicated proteins after different extents of Tpr depletion. The asterisk indicates the quantified band. (E) WB analysis of Tpr, Mad1, Mad2, and Mps1 
upon partial depletion of Mad1, Mad2, or Mps1 by RNAi. + and – signs indicate control and depleted cells, respectively. (F) IP from mitotic HeLa cells 
with or without Mps1 inhibition using a Tpr antibody followed by WB against Tpr, Mps1, Mad1, and t-Mad2. -Tubulin was used as loading control in 
all experiments. OE, overexposed.
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conclude that Tpr limits the production of Mad1–c-Mad2 by reg-
ulating SAC proteostasis.
Overexpression of Mad2 restores  
Mad2 KT levels and SAC robustness  
in Tpr-depleted cells
Next, we tested whether the reduced Mad2 protein levels are 
responsible for the weaker SAC response in Tpr-depleted cells 
by investigating the ability of Mad2 overexpression to rescue 
Tpr depletion. For this purpose, we used a cell line express-
ing 1.5× GFP-Mad2 levels relative to endogenous Mad2 
(Fig. S1 I). First, we quantified Mad2 levels at unattached KTs 
in control and Tpr-depleted cells overexpressing GFP-Mad2 by 
immunofluorescence microscopy upon MT depolymerization 
with nocodazole (Figs. 2 B and S1 J). We found that GFP-Mad2 
overexpression restores t-Mad2 levels at unattached KTs to 
90% of control levels in Tpr-depleted cells (Fig. 2 B). Next, 
we quantified the mitotic duration after nocodazole treatment 
in Tpr-depleted cells overexpressing GFP-Mad2 and found a 
significant rescue of mitotic duration relative to parental cells 
depleted of Tpr (15.8 ± 7.6 h vs. 11.7 ± 7.1 h; n = 115 cells, 
P < 0.01; Fig. 1 I). We conclude that the proteolytic degrada-
tion of Mad2 caused by Tpr depletion is the leading cause of 
reduced Mad2 levels at unattached KTs and, consequently, of 
the weaker SAC response.
A mechanism for regulation of SAC 
proteostasis and robustness by Tpr
Purified Mad1 forms a high-affinity and stable complex with 
Mad2 in vitro (Sironi et al., 2002; De Antoni et al., 2005), and 
Mad1 interacts with Mad2 throughout the cell cycle (Chen et al., 
1999; Chung and Chen, 2002; Fava et al., 2011). Here we pro-
pose that the TM2 complex stabilizes Mad1–c-Mad2 in vivo, 
preventing it from being degraded by the proteasome. Interest-
ingly, Tpr and respective orthologues in yeast and plants have 
been implicated in protein SUMOylation at the nuclear periph-
ery, possibly by locally regulating the targeting and/or function 
of the SUMO-isopeptidases Ulp1/SENP1/SENP2 (Zhao et al., 
2004; Xu et al., 2007; David-Watine, 2011). Here we found 
that Tpr is required to recruit SENP1, but not SENP2, to NPCs 
(Fig. 5 G). Because Tpr depletion also affects Mad1–c-Mad2 
recruitment to NPCs, Mad1–c-Mad2 is not able to interact with 
either SENP1 or SENP2 at the NPCs, which might alter normal 
Mad1–c-Mad2 proteostasis. In agreement with this model, ei-
ther SENP1 or SENP2 depletion by RNAi reduces total Mad1 
and Mad2 levels by 50% (Fig. 5 H). Given so, it is tempting to 
speculate that the requirement of Tpr for a robust SAC response 
by regulating Mad1 and Mad2 protein levels before mitosis 
might involve spatial control of SUMO-mediated proteolysis at 
the NPCs, but further studies will be necessary to directly test 
this hypothesis.
Materials and methods
Cell culture and drug treatments
HeLa or U2OS cells were cultured in DMEM with 10% FBS (Invitrogen) 
in a 37°C incubator with 5% CO2 and a humidified atmosphere. MT 
(Fig. S1 E), and quantified Mad1 and c-Mad2 levels at un-
attached KTs by fluorescence microscopy. In contrast to the 
decrease observed in c-Mad2, but not Mad1, after Tpr deple-
tion, we found that both Mad1 and c-Mad2 levels are reduced 
to a similar extent after partial Mps1 depletion (Fig. S1, F–H). 
This suggests that the role of Tpr in regulating c-Mad2, but not 
Mad1, levels at KTs is independent of Mps1. Finally, we de-
termined whether Mps1 kinase activity is required for the inter-
action between Mad1, Mad2, and Tpr. Based on Tpr IP, Tpr still 
interacts with Mad1 and Mad2 in mitotic extracts after Mps1 
inhibition (Fig. 4 F). Thus, TM2 complex formation is indepen-
dent of KTs and Mps1 kinase activity.
Tpr is required for SAC proteostasis 
throughout the cell cycle
It has been proposed that Tpr acts at NPCs as part of a surveil-
lance system that regulates the export of unspliced mRNA into 
the cytoplasm (Green et al., 2003; Galy et al., 2004; Vinciguerra 
et al., 2005; Xu et al., 2007; Coyle et al., 2011; Rajanala and 
Nandicoori, 2012). We tested whether the observed deficit in 
SAC protein levels reflects a defect in mRNA transcription/ 
processing by quantifying the content of mature mRNA of several 
SAC genes with real-time PCR. We found similar expression 
levels for mad2, mps1, p31, and cdc20 mRNAs in control 
and Tpr-depleted cells, either in interphase or mitosis (Fig. 5, 
A and B). Interestingly, mad1 mRNA expression in interphase is 
significantly increased (P < 0.01) after Tpr depletion (Fig. 5 A), 
which might reflect a feedback response caused by reduced 
Mad1 protein levels. Overall, these results demonstrate that 
the decrease in Mad1, Mad2, and Mps1 after Tpr depletion is 
not caused by a reduction of the respective mRNAs.
Because Tpr interacts with Mad1, Mad2, and Mps1 and the 
overall levels of these proteins were reduced upon Tpr depletion, 
we next investigated a possible role of Tpr in SAC proteostasis by 
comparing Mad1, Mad2, and Mps1 protein levels in Tpr-depleted 
extracts derived from asynchronous, G2-enriched, and mitotic 
cells. In addition, we evaluated whether inhibition of the 26S pro-
teasome by addition of MG132 rescues the effect of Tpr deple-
tion. We found that only asynchronously growing cells partially 
recover Mad1, Mad2, and Mps1 protein levels after a 2-h treat-
ment with MG132 (Fig. 5 C), which suggests that Tpr regulates 
the degradation of these proteins before G2 and the commitment 
to mitosis. Next, we tested whether the observed Mad1, Mad2, 
and Mps1 degradation after Tpr depletion is responsible for the 
reduced production of Mad1–c-Mad2 by c-Mad2 IP from control 
and Tpr-depleted interphase cells in the presence or absence of 
MG132. We found that Tpr depletion causes a decrease in Mad1 
and t-Mad2 present in the extract (input), as well as in the Mad1–
c-Mad2 levels. This decrease was partially rescued by incubation 
with MG132 for 2 h (Fig. 5 D). Finally, we tested whether Tpr is 
required for the normal turnover of Mad1, Mad2, or Mps1 by 
treating control and Tpr-depleted cells with cycloheximide to in-
hibit de novo protein synthesis and monitored the respective pro-
tein half-life by WB. We found that Tpr-depleted cells show a 
significantly shorter half-life for Mad1, Mad2, and, to a lesser 
extent, Mps1 (Fig. 5, E and F). Based on these experiments, we 
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Figure 5. Tpr is required for SAC proteostasis throughout the cell cycle. (A and B) Normalized expression of tpr, mad1, mad2, mps1, cdc20, and p31 
in control and Tpr-depleted asynchronous or mitotic cells. Error bars represent standard deviations from three independent experiments. (C) WB analysis 
of asynchronous, G2, and mitotic enriched HeLa cell extracts from control (+) and Tpr-depleted () cells with (+) or without () MG132 with the indicated 
antibodies. The percentage of protein levels relative to controls is indicated. (D) c-Mad2 IP from asynchronous and mitotic HeLa cells with (+) or without () 
Tpr, in the presence (+) or absence () of MG132. (E and F) Cells with or without Tpr were treated with cycloheximide (CHX) for various time points as 
indicated. Total protein extracts of asynchronous HeLa cells were analyzed by WB to detect Tpr, Mps1, Mad1, and t-Mad2 in control and Tpr-depleted 
cells. -Tubulin was used as a loading control. *, P < 0.05; **, P < 0.01; ***, P < 0.001. The error bars indicate standard deviations from two indepen-
dent experiments. (G) Immunodetection of Mad1 (red), SENP1, and SENP2 (green) in Tpr-depleted cells (). A nondepleted cell (+) was used as internal 
control. DNA was counterstained with DAPI (blue). (H) WB analysis of asynchronous cell extracts in control and after SENP1 or SENP2 RNAi. The percent-
age of protein levels relative to controls is indicated. -Tubulin was used as a loading control. Bar, 10 µm.
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after three prebleach images were acquired. The fluorescence intensity of 
the bleached area was normalized using the intensity of an ROI distant 
to the bleached area (in the same cell) after background subtraction. For 
calculations of half-time of recovery and percentage of recovery, exponen-
tial curve fit was applied to the obtained data using GraphPad Prism 5 
(GraphPad Software).
IP and WB
HeLa cells were resuspended in NP-40 lysis buffer (0.5% NP-40). Cell ex-
tracts were precleared with protein G magnetic beads (New England Bio-
labs, Inc.). The cleared lysates were then incubated with the respective 
antibody. The immunoprecipitates were captured with protein G magnetic 
beads. The immunoprecipitates were eluted from the beads with SDS sam-
ple buffer and subjected to WB analysis. The following antibodies were 
used for WB: rabbit anti-Tpr antibody (NB100-2866, 1:1,000; Novus Bio-
logicals), mouse anti-Mps1 antibody (NT clone 3-742-1, 1:500; Merck 
Millipore), rabbit anti-Mad2 antibody (A300-301 A-2, 1:1,000; Bethyl 
Laboratories, Inc.), rabbit anti-Mad1 antibody (1:1,000; provided by 
P. Meraldi), mouse anti-Mad1 (1:100; Santa Cruz Biotechnology, Inc.), 
rabbit anti-Cdc20 antibody (sc-5296, 1:1,000; Santa Cruz Biotechnology, 
Inc.), rabbit anti-SENP1 or SENP2 (1:2,000), mouse anti-GFP (1:1,000), 
and mouse anti–-tubulin antibody (clone B-512, 1:5,000; Sigma-Aldrich). 
Goat anti–rabbit, anti–mouse, or anti–sheep antibodies were used as sec-
ondary antibodies (1:5,000; Jackson ImmunoResearch Laboratories, Inc.). 
The WBs were quantified using a calibrated densitometer (GS800; Bio-
Rad Laboratories) and Quantity One 1-D Analysis Software, version 4.6 
(Bio-Rad Laboratories), which highlights saturated pixels when signal inten-
sity falls off the linear range. Only exposures without saturated pixels were 
used and were normalized for the loading control (-tubulin).
Local affinity purification (LAP)-Mad1 purification and mass spectrometry
GFPLAP hMad1 was generated in HeLa cells as described previously 
(Cheeseman et al., 2004). In brief, a pBABE (MMLV)-based plasmid con-
taining GFPLAP hMad1 (or mutant) was cotransfected into 293-GP cells with 
a VSVG-containing plasmid to generate virus. After infection with the retro-
virus, HeLa cells were selected using 2 µg/ml Blasticidin. Resistant cells 
were sorted by FACS to generate clonal cell lines. To conduct the affinity 
purifications, cell lines were grown to 70–90% confluency, and then treated 
with 3.33 µM nocodazole for 16 h. A mitotic shake-off was then per-
formed and cells were pelleted at 1,000 g. A modified cross-linking proto-
col was developed based on Klockenbusch and Kast (2010). In brief, the 
cell pellets were resuspended with 0.4–1.2% formaldehyde in PBS and 
rocked gently for 10 min. After pelleting at 1,000 g, the cell pellet was 
quenched with 0.125 M glycine in PBS for 10 min. The cells were pro-
cessed by sonication and treatment with detergent to solubilize cross-linked 
cell material, then a one-step LAP purification was performed as described 
previously (Cheeseman and Desai, 2005) in the presence of 300 mM KCl. 
In brief, processed lysate was bound to anti-GFP coupled beads for 1 h. 
The beads were then washed, and bound protein was eluted with 0.1 M 
glycine. Elutions were TCA-precipitated, and the protein pellet was resus-
pended with 8 M urea. Cross-linking reversal was performed at 95°C for 
5 min before tryptic digestion. Purified proteins were identified by mass 
spectrometry using an ion trap mass spectrometer (LTQ XL; Thermo Fisher 
Scientific) with a reverse phase gradient over C18 resin (Phenomenex) and 
SEQUEST software as described previously (Washburn et al., 2001).
PLA
For PLA, we used primary antibodies raised in different species against Tpr 
(Novus Biologicals) or Nup107 (provided by V. Doye, Institute Jacques 
Monod, Paris, France) and Mad1 (provided by A. Santamaria), which 
were subsequently detected by species-specific secondary antibodies con-
jugated with PLA probes according to the manufacturer´s instructions (Duolink; 
Olink Bioscience).
RNA extraction and transcription analysis by RT-qPCR
Total RNA was isolated from interphase, and mitotic HeLa cells (shake-off) 
were treated with nocodazole and MG132 using an RNeasy Mini kit ac-
cording to the manufacturer´s instructions (QIAGEN). For cDNA synthesis, 
1 µg of total RNA was transcribed with the iScript Select cDNA Synthesis 
kit (Bio-Rad Laboratories) using the random primers and oligo(dTs) sup-
plied, following the manufacturer’s instructions. For each analysis, gapdh 
was used for normalization. RT-qPCRs were performed in the iCycler iQ5 
Real-Time PCR Detection System (Bio-Rad Laboratories). The data obtained 
were analyzed using the Bio-Rad iQ5 Optical System Software v2.1 (Bio-
Rad Laboratories).
depolymerization in HeLa and U2OS cells was induced by nocodazole 
at 1.6 µM for 2–16 h, according to the experiment. To inhibit the pro-
teasome, induce a metaphase arrest, and prevent exit due to a com-
promised SAC, cells were treated with 5 µM MG132 (EMD Millipore) 
for 2 h. For Mps1 inhibition, cells were treated with 10 µM Mps1-IN-1 
(provided by N. Gray) for 1 h. Mis12-Mps1 expression was induced with 
1 µg/ml doxycycline (Sigma-Aldrich) for 24 h. G2-enriched extracts were 
derived from cells incubated for 16 h with the Cdk1 inhibitor RO3306 
(Roche), whereas mitotic extracts were obtained by shake-off upon no-
codazole treatment for 16 h. For determination of protein half-life, HeLa 
cells were exposed to 10 µg/ml cycloheximide (Sigma-Aldrich) in growth 
medium, both in the presence or absence of Tpr. Cells were incubated at 
37°C with 5% CO2 for different time points and subsequently harvested 
for immunoblotting.
Live cell imaging
Control and Tpr-depleted cells (parental HeLa cells and HeLa cells stably 
expressing GFP-Mad2 or Tpr-GFP) were imaged with phase-contrast micros-
copy at 37°C in DMEM or L15 medium (Invitrogen) supplemented with 10% 
FBS. To determine the time between NEB and anaphase onset, images were 
captured on an inverted microscope (TE2000U; Nikon; 20× objective lens; 
LWD; 0.4 NA) equipped with an electron-multiplying charge-coupled device 
(CCD) camera (iXonEM+; Andor Technology) every 2 min for 12 h using 
the NIS-Elements Viewer software (Nikon). To measure mitotic timing and to 
determine the cell fate after interfering with MTs, nocodazole was added 1 h 
after filming, and images were acquired on an inverted microscope (Axio-
vert 200M; Carl Zeiss; 20× objective lens; A-Plan Ph1; 0.3 NA) equipped 
with a CCD camera (CoolSNAP HQ2; Photometrics) every 10 min for 48 h 
using the Micro-Manager 1.3 software (www.micro-manager.org).
Immunofluorescence microscopy
Cells were grown on poly-l-lysine–coated coverslips and fixed either with 
4% paraformaldehyde or ice-cold methanol, then extracted simultane-
ously or subsequently with 0.1–0.2% Triton X-100. After short washes in 
PBS and blocking with 10% FBS in PBS, cells were incubated with pri-
mary antibodies after short washes and incubation with the respective 
secondary antibodies. DNA was counterstained with DAPI (1 µg/ml; 
Sigma-Aldrich) before coverslips were mounted in 90% glycerol + 10% Tris, 
pH 8.5, + 0.5% N-propyl gallate on glass slides. Images were acquired on 
a AxioImager Z1 (63× Plan-Apochromatic oil differential interference con-
trast objective lens, 1.4 NA) equipped with a CCD (Axiocam MR) camera 
using the Zen software (all from Carl Zeiss) and blind deconvolved using 
Autoquant X (Media Cybernetics). Images were processed in Photoshop 
CS4 (Adobe) and represent either maximum projections of a deconvolved 
stack or a single slice in the case of Figs. 3 E and 5 G. Mouse anti-Mad1 
(generated against full-length Mad1, 1:500; provided by A. Santamaria 
and E. Nigg, Biozentrum, Basel, Switzerland), rabbit anti-Mad1 (gener-
ated against full-length Mad1, 1:1,000; provided by P. Meraldi, Uni-
versity of Geneva, Switzerland), mouse anti–c-Mad2 (generated against 
full-length Mad2, 1:500; provided by A. Santamaria), rabbit anti–t-Mad2 
(1:300; Bethyl Laboratories, Inc.), sheep anti–o-Mad2 (generated against 
full-length Mad2, 1:200; provided by S. Taylor, University of Manchester, 
UK), rabbit anti-Cdc20 (1:100; Santa Cruz Biotechnology, Inc.), mouse 
anti-Mps1 (1:100; Merck Millipore), rabbit anti-Tpr (1:500; Novus Biologi-
cals), sheep anti-BubR1 (generated against aa 2–422, 1:300; provided by 
S. Taylor), rabbit anti-SENP1 or -SENP2 (generated against aa 273–449 
and aa 1–92, respectively; 1:1,000; provided by M. Dasso, National 
Institutes of Health, Bethesda, MD), and human anticentromere antibodies 
(ACAs; 1:5,000, provided by B. Earnshaw; or 1:2,000, Fitzgerald Indus-
tries International) were used as primary antibodies, and Alexa Fluor 488, 
568, and 647 (Invitrogen) were used as secondary antibodies (1:1,000).
Fluorescence quantification
For quantification of fluorescence, a custom routine written in MATLAB 
(MathWorks) was used. Protein accumulation was measured by quantifica-
tion of pixel gray levels of the focused z plane within a region of interest 
(ROI). Background fluorescence was measured outside the ROI and sub-
tracted. For quantifications at KTs, the ROI encompassed a single KT or KT 
pair, and results were normalized against ACA or Mad1 signals. Approxi-
mately 1,000 KT pairs from 30 cells were analyzed for each protein.
FRAP
FRAP of GFP-Mad2 in control and Tpr RNAi cells treated with nocodazole 
was performed on an inverted microscope (TE2000U) equipped with an 
electron-multiplying CCD camera (iXonEM+). Images were acquired every 
800 ms. Bleaching in an ROI at a single KT was conducted for 400 ms 
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